Share on LinkedInShare on LinkedIn

ARTICLE · 23 MARCH 2017

Current Practice And FAS Further Plans

Igor Artemiev, head of FAS (Federal Antimonopoly Service) gave a briefing on "Current practice and further plans of FAS " which took place on March 6, 2017 in the office of AEB.

RussiaAntitrust/Competition Law

Igor Artemiev, head of FAS (Federal Antimonopoly Service) gave a briefing on "Current practice and further plans of FAS " which took place on March 6, 2017 in the office of Association of European Business (AEB). The briefing was attended by the association members and representatives of mass media.

In the course of this meeting, the parties discussed a broad spectrum of topics related to antitrust regulation in various spheres of national economy. The major part of this event was dedicated to the issues of antitrust regulations in the field of pharmaceuticals and state procurement of medicines.

Specifically, Igor Artemiev stated that FAS frowns upon a so-called "odd man out" rule applied in state procurement of medicinal drugs and products. According to this rule, if there are at least two or more offers for supplying medicinal drugs produced in the Eurasian Economic Union in the tender procedure, the foreign suppliers are not allowed to participate. According

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from